🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Advanced kidney disease with it's associated heart and blood vessel problem...
Status
Completed
Location
St. Paul's Hospital
Start Date
2005-04
Trial ID
NCT00231803
This is a 12-Week clinical trial in patients with Primary hypercholesterole...
Status
Completed
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT00479388
Treatments Being Tested
Alirocumab (SAR236553/REGN727) is a fully human monoclonal antibody that bi...
Status
Completed
Location
Investigational Site Number 840857
Start Date
2012-07
Trial ID
NCT01644175
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy and the saf...
Status
Completed
Location
Multiple Locations
Start Date
2000-05-03
Trial ID
NCT03884452
Treatments Being Tested
Peripheral arterial disease (PAD) occurs when arteries become narrowed or h...
Status
Completed
Location
Baylor College of Medicine
Start Date
2004-04
Trial ID
NCT00687076
Primary Objective: To provide participants with severe hypercholesterolemi...
Status
Completed
Location
Investigational Site Number 040001
Start Date
2015-06-23
Trial ID
NCT02476006
This phase II, open-label research study was conducted in 129 healthy volun...
Status
Completed
Location
University of Pennsylvania
Start Date
2006-03
Trial ID
NCT00359281
Treatments Being Tested
In patients with coronary artery disease and a LDL-C level between 2.5 mmol...
Status
Completed
Location
Multiple Locations
Start Date
2005-11
Trial ID
NCT00166530
Treatments Being Tested
In this study, we compared the survival benefit of breast cancer patients w...
Status
Unknown
Location
PUMCH
Start Date
2019-03-28
Trial ID
NCT03971019
Treatments Being Tested
Primary Objective: To demonstrate the reduction of low-density lipoprotein...
Status
Completed
Location
Investigational Site Number 410001
Start Date
2015-01
Trial ID
NCT02289963
Treatments Being Tested